Thursday, July 16, 2020 3:55:00 PM
By itself, it may not be the answer to everything, which is why I'm happy with the development of other technologies. If PLX-PAD reduced the deaths in covid-19 by 80% it would still be a serious disease, especially considering that many people who recover continue to have problems that may never be fully recovered from. I believe to limit the negative side effects, PLX-PAD or something will be needed well before ventilators to avoid other organ damage. No doubt, PLX-PAD will be more expensive than many of the therapies they're working with, on the other hand, if it prevents or improves on other organ damage, while others save a life, but leave the patient in a more weakened state, the added cost will save on treatment in the long run.
Gary
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM